Renascience Inc. (TYO:4889)
1,547.00
+4.00 (0.26%)
Aug 6, 2026, 11:26 AM JST
Renascience Market Cap
Renascience has a market cap or net worth of 21.26 billion as of August 5, 2026. Its market cap has decreased by -39.95% in one year.
Market Cap
21.26B
Enterprise Value
17.86B
Revenue
68.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,547.00
ChartMarket Cap Chart
Since September 24, 2021, Renascience's market cap has increased from 10.13B to 21.26B, an increase of 109.76%. That is a compound annual growth rate of 16.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 21.26B | 15.60% |
| Dec 30, 2025 | 18.39B | 387.08% |
| Dec 30, 2024 | 3.78B | -31.57% |
| Dec 29, 2023 | 5.52B | 18.26% |
| Dec 30, 2022 | 4.67B | -46.27% |
| Dec 30, 2021 | 8.68B | -14.33% |
| Sep 24, 2021 | 10.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Heartseed | 39.53B |
| Cuorips | 37.45B |
| Healios K.K. | 31.73B |
| Japan Tissue Engineering | 30.62B |
| AnGes | 18.75B |
| StemRIM | 18.55B |
| CanBas | 13.95B |
| RaQualia Pharma | 12.70B |